Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SynInnova is a premier contract research organization (CRO) and specialty chemical supplier based in Edmonton, Canada, specializing in complex organic synthesis and medicinal chemistry. The company offers an extensive catalog of over 10,000 high-purity research chemicals, including stable isotope-labeled compounds, metabolites, impurities, and advanced building blocks. SynInnova provides custom synthesis services to support global pharmaceutical and biotechnology firms in their drug discovery and development efforts. Their technical expertise enables the production of challenging molecules across diverse therapeutic areas such as oncology and neurology. By delivering high-quality analytical standards and chemical intermediates, SynInnova helps accelerate the timeline from lead optimization to clinical candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SynInnova.